Board of Directors
Dr Geoffrey N Vernon BPharm, PhD, MBA, Ch.Dir.
Non-Executive Chairman
Dr Vernon is a former Executive Director of Rothschild Asset Management and partner of the venture capital group Advent Limited. He joined AMS as a non-executive director in July 1998 and became Chairman in January 2001. He has over 20 years experience in healthcare and life sciences. He is a non-executive chairman and director of a number of quoted and privately owned companies. He is a Chartered Director of the Institute of Directors.
Dr Don W Evans BChemEng, MASc, PhD
Chief Executive Officer
After completing a degree in Chemical Engineering at the University of Queensland and a PhD in Biomedical Engineering at the University of Toronto, Dr Evans joined Johnson & Johnson UK where he worked for 19 years in Research & Development and Manufacturing. He was subsequently appointed as Vice-President of European Operations for Johnson & Johnson Professional. Dr Evans joined AMS in 1997 as Operations Director and was appointed Managing Director of Advanced Woundcare in January 1999.He became Group Chief Executive in January 2000.
Mary G Tavener ACMA, MCT, BA (Hons) Chem (Oxon)
Finance Director
Ms Tavener joined AMS as Finance Director in 1999. Prior to this she was the Group Financial Controller at BTP plc during a period of considerable corporate activity and was involved in the acquisition and disposal of several businesses that repositioned BTP plc as a fine chemical company. Her experience has been gained in manufacturing and she has held financial positions with Cadburys Ltd and Parker Hannifin, a US Engineering Corporation. Prior to BTP plc, she was the Finance Director of Churchill Tableware Ltd.
A Chris Meredith BSc (Hons)
Chief Operating Officer
Mr Meredith joined AMS as Group Commercial Director in July 2005. He was appointed managing Director of Advanced Woundcare in February 2008 and in January 2010, he became Chief Operating Officer for the Group. He began his career in sales for Beecham Pharmaceuticals and has continued to hold commercial roles within the healthcare industry ever since. His experience covers contract manufacturing, product development, clinical research and branded product sales all within the medical device, pharmaceutical or consumer healthcare markets. Mr Meredith has previously held senior commercial positions at Cardinal Health, Banner Pharmacaps, Aster Cephac and Smiths Industries.
Stephen G Bellamy BCom & ACA (NZ)
Non-Executive Director
Mr Bellamy was appointed as non-executive director of AMS on 20 February 2007. He is currently CEO and a founding partner of Accretion Capital LLP (provider of strategic capital to emerging European technology companies), Chairman of The First Close Technology Fund (which invests in early stage UK technology companies) and non-executive director of Clarity Commerce Solutions plc, BeCrypt Ltd and Image Metrics Ltd (all of which are technology companies). Formerly, an executive director of Sherwood International plc, and Brierley Investments' London operations, he has also held a number of other non-executive directorships and advisory roles including Budgens plc, a UK food retailer and Dr. Foster Limited, a provider of information services to the UK health industry. He is a New Zealand qualified chartered accountant.
Penelope Anne Freer
Senior Independent Non-Executive Director
Ms Freer was appointed as senior independent non executive director of AMS on 1st March 2010. She is currently the senior independent non executive director of Sinclair Pharma plc and a non executive director of Empresaria Group plc. S he is a co-founder and director of Capital Markets Group, an FSA authorised advisory business. With 25 years experience in investment banking she was formerly Head of Equities for Robert W Baird in London and prior to this held senior positions at Credit Lyonnais and NatWest Markets.
Published : 05/07/2010 12:47:20